We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

49 hedge funds and large institutions have $145M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $149M → $145M (-$3.88M)

4% less funds holding

Funds holding: 51 → 49 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WCMNY
Westchester Capital Management (New York)
New York
+$9.41M
2
AC
Aristeia Capital
Connecticut
+$9.17M
3
CCA
Castle Creek Arbitrage
Colorado
+$5.38M
4
MC
Meteora Capital
Florida
+$3.72M
5
UOC
UBS O'Connor
Illinois
+$2.39M

Top Sellers

Rank Fund Capital Flow
1
KL
KIM LLC
Kansas
-$8.06M
2
CSS
Cubist Systematic Strategies
Connecticut
-$6.32M
3
Millennium Management
Millennium Management
New York
-$6.29M
4
6CM
683 Capital Management
New York
-$5.08M
5
FTCM
First Trust Capital Management
Illinois
-$2.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aristeia Capital
Connecticut
$13.4M +$9.17M +903,138 +224%
WCMNY
2
Westchester Capital Management (New York)
New York
$9.74M +$9.41M +926,753 +3,705%
GCL
3
Glazer Capital LLC
New York
$8.7M +$229K +22,530 +3%
MI
4
MMCAP International
Cayman Islands
$8.18M – – –
FTCM
5
Fir Tree Capital Management
New York
$8.1M -$1.64M -161,301 -17%
HSBC Holdings
6
HSBC Holdings
United Kingdom
$7.23M +$61.4K +6,050 +0.9%
6CM
7
683 Capital Management
New York
$7.15M -$5.08M -500,000 -42%
CF
8
Cantor Fitzgerald
New York
$6.03M +$3.05K +300 +0.1%
CCA
9
Castle Creek Arbitrage
Colorado
$5.42M +$5.38M +530,000 New
MF
10
Magnetar Financial
Illinois
$5.13M -$148K -14,555 -3%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
11
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$5.13M – – –
PSAMP
12
P. Schoenfeld Asset Management (PSAM)
New York
$5.13M – – –
ACM
13
Atalaya Capital Management
New York
$5.12M – – –
PC
14
Periscope Capital
Ontario, Canada
$4.7M -$131K -12,952 -3%
RCM
15
Radcliffe Capital Management
Pennsylvania
$4.22M – – –
Calamos Advisors
16
Calamos Advisors
Illinois
$3.84M – – –
Jane Street
17
Jane Street
New York
$3.8M -$1.42K -140 -0%
MC
18
Meteora Capital
Florida
$3.75M +$3.72M +366,183 New
AGC
19
Angelo Gordon & Co
New York
$3.07M – – –
UOC
20
UBS O'Connor
Illinois
$2.41M +$2.39M +235,390 New
BFM
21
Boothbay Fund Management
New York
$2.08M +$2.06M +202,553 New
AA
22
AQR Arbitrage
Connecticut
$1.95M -$93.4K -9,200 -5%
WRBC
23
W.R. Berkley Corp
Connecticut
$1.77M – – –
RCM
24
Rivernorth Capital Management
Florida
$1.76M – – –
PMAM
25
Picton Mahoney Asset Management
Ontario, Canada
$1.54M – – –
1
2 3

ORIA Hedge Fund Activity: Q1 2023 in Review

49 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q1 2023, worth a combined $145M — down 2.6% from $149M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ORIA and 7 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was Westchester Capital Management (New York), adding an estimated $9.41M. The largest seller was KIM LLC, exiting entirely with an estimated $8.06M sold.

  • 49 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q1 2023, down from 51 in Q4 2022.
  • Funds reported $145M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q1 2023, down 2.6% quarter-over-quarter.
  • 7 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q1 2023 and 9 closed out, a net change of -2 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q1 2023 was Westchester Capital Management (New York), an estimated $9.41M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q1 2023 was KIM LLC, an estimated $8.06M sold.

Based on aggregated 13F filings for Q1 2023.